Innovation Medical Management Co., Ltd.
Symbol: 002173.SZ
SHZ
8.86
CNYMarktpreis heute
-107.2347
P/E-Verhältnis
0.1986
PEG-Verhältnis
3.91B
MRK Kapital
- 0.00%
DIV Rendite
Innovation Medical Management Co., Ltd. (002173-SZ) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 2371.68 | 583.2 | 658.5 | 799.8 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | -32.02 | 20.1 | 0 | 574 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 410.45 | 107 | 60.9 | 94.3 | ||||||||||||||||||||
balance-sheet.row.inventory | 157.59 | 41.8 | 49.3 | 43 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 8.09 | 1.1 | 3 | 2.9 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 2947.81 | 733.1 | 771.6 | 940 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 5372.28 | 1349.8 | 1375.5 | 1397 | ||||||||||||||||||||
balance-sheet.row.goodwill | 3.95 | 1 | 1 | 1 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 502.52 | 129.6 | 121.8 | 125.2 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 506.47 | 130.5 | 122.8 | 126.2 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 94.5 | -4.9 | 17.9 | -554.3 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 59.97 | 17 | 14.4 | 13.8 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 117.43 | 55.9 | 37.4 | 633.5 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 6150.64 | 1548.4 | 1568 | 1616.2 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 9098.45 | 2281.5 | 2339.7 | 2556.2 | ||||||||||||||||||||
balance-sheet.row.account-payables | 766.16 | 208.1 | 210.1 | 183.4 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 157.13 | 48.2 | 36.9 | 29.9 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 18.08 | 6.6 | 5.8 | 5.9 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 80.78 | 20.3 | 21.6 | 33.9 | ||||||||||||||||||||
Deferred Revenue Non Current | 16.99 | 4.2 | 4.8 | 5.2 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 177.64 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 58.66 | 0 | 70.1 | 46 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 338.5 | 85 | 112 | 219.3 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 80.78 | 20.3 | 21.6 | 33.9 | ||||||||||||||||||||
balance-sheet.row.total-liab | 1566.11 | 410.4 | 434.4 | 565.3 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 1800.21 | 449 | 453.1 | 453.6 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | -5168.47 | -1304.2 | -1269.7 | -1184.2 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 2861 | 43.8 | 43.4 | 40.1 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 8035.94 | 2681.5 | 2677.5 | 2680.3 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 7528.69 | 1870.2 | 1904.3 | 1989.8 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 9098.45 | 2281.5 | 2339.7 | 2556.2 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 3.65 | 0.9 | 0.9 | 1.1 | ||||||||||||||||||||
balance-sheet.row.total-equity | 7532.33 | 1871.1 | 1905.2 | 1990.9 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 9098.45 | - | - | - | ||||||||||||||||||||
Total Investments | 62.48 | 15.2 | 17.9 | 19.8 | ||||||||||||||||||||
balance-sheet.row.total-debt | 237.91 | 68.5 | 58.4 | 63.8 | ||||||||||||||||||||
balance-sheet.row.net-debt | -2093.02 | -494.5 | -600.1 | -161.9 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -35.11 | -34.3 | -73.9 | -105.1 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.63 | 106.7 | 110.3 | 117.5 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -3.2 | -1.4 | -3.9 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 3.2 | 1.4 | 3.9 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -79.95 | -43 | 9.8 | 18.9 | ||||||||||||||||||||
cash-flows.row.account-receivables | -49.07 | -49.1 | 36 | 11.7 | ||||||||||||||||||||
cash-flows.row.inventory | 6.82 | 6.8 | -6.7 | -8 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | 2.4 | -18.1 | 19.1 | ||||||||||||||||||||
cash-flows.row.other-working-capital | -37.7 | -3.2 | -1.4 | -3.9 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 89.42 | -18.3 | -70.7 | 12 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -19.01 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -90.18 | -96.2 | -123.2 | -110.7 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0.13 | 0.3 | 0.2 | 35.6 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | -320.4 | -320 | -30 | -695 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 625.03 | -0.3 | 612.7 | 710.5 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | -14.96 | 0.9 | 0.3 | 7.2 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -104.93 | -415.3 | 460 | -52.4 | ||||||||||||||||||||
cash-flows.row.debt-repayment | -63 | -23 | -12 | -33 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 48.4 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | -48.4 | ||||||||||||||||||||
cash-flows.row.dividends-paid | -1.66 | -1.5 | -0.8 | -2.4 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 50.2 | -10.5 | 9.8 | -76.1 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 11.54 | -5 | -3 | -111.4 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.03 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -112.43 | -409.3 | 432.6 | -120.4 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2002.99 | 249 | 658.3 | 225.7 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2115.42 | 658.3 | 225.7 | 346.1 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | -19.01 | 11 | -24.4 | 43.4 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -90.18 | -96.2 | -123.2 | -110.7 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | -109.18 | -85.2 | -147.6 | -67.4 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 802.72 | 805.6 | 709.7 | 711.5 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 714.85 | 713.4 | 679.1 | 665.4 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 87.87 | 92.2 | 30.6 | 46.2 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 25.73 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 9.18 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | -8.35 | -9.3 | 83.7 | 83 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 122.74 | 126.4 | 122.5 | 125.5 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 837.59 | 839.8 | 801.6 | 790.9 | ||||||||||||||||||||
income-statement-row.row.interest-income | 18.57 | 17.4 | 14.6 | 13.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 3.49 | 3.6 | 3.4 | 6.1 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 9.18 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -8.35 | -9.3 | -3.7 | 2.3 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -8.35 | -9.3 | 83.7 | 83 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -8.35 | -9.3 | -3.7 | 2.3 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 3.49 | 3.6 | 3.4 | 6.1 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | -2.41 | 106.7 | 110.3 | 117.5 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | -29.94 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | -27.53 | -25.6 | -71.6 | -107.2 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | -35.87 | -35 | -75.3 | -104.8 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | -0.7 | -0.7 | -1.4 | 0.3 | ||||||||||||||||||||
income-statement-row.row.net-income | -35.11 | -34.3 | -73.9 | -105.1 |
Häufig gestellte Frage
Wie hoch ist die Innovation Medical Management Co., Ltd. (002173.SZ) Gesamtvermögen?
Innovation Medical Management Co., Ltd. (002173.SZ) Gesamtvermögen ist 2281472772.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 399763679.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.109.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -0.246.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -0.044.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -0.034.
Was ist der Innovation Medical Management Co., Ltd. (002173.SZ) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -34287743.350.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 68543479.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 126432642.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 543823060.000.